Drugs / Muscle Derived Stem Cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02208713 | May 2014 → Nov 2017 | muscular dystrophy | Royan Institute | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Muscle Derived Stem Cell | “Intramuscular Transplantation of Autologous Muscle Derived Stem Cell(MDSC) and Adipose Derived Mesenchymal Stem Cells (AD-MSC) in Patients With Facioscapulohumeral Dystrophy...” NCT02208713 ↗ |
| Known as | MDSC | “a sample of patient's muscle is taken from Biceps Femoralis to isolate and culture of MDSC.” NCT02208713 ↗ |